Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.
 Back to Details

Connection

Jennifer Dotson to Tumor Necrosis Factor-alpha

This is a "connection" page, showing publications Jennifer Dotson has written about Tumor Necrosis Factor-alpha.

 
Connection Strength
  
 
 
0.904
  
  1. Dotson JL, Crandall W, Mousa H, Honegger JR, Denson L, Samson C, Cunningham D, Balint J, Dienhart M, Jaggi P, Carvalho R. Presentation and outcome of histoplasmosis in pediatric inflammatory bowel disease patients treated with antitumor necrosis factor alpha therapy: a case series. Inflamm Bowel Dis. 2011 Jan; 17(1):56-61.
    View in: PubMed
    Score: 0.307
  2. Davidson N, Morris GA, Wright MA, Brock G, Boyle B, Dotson JL, Michel HK, Maltz RM. Predictors of antitumor necrosis factor primary nonresponse and drug durability in pediatric inflammatory bowel disease. J Pediatr Gastroenterol Nutr. 2025 Oct; 81(4):1024-1033.
    View in: PubMed
    Score: 0.210
  3. Iovino NA, McClinchie MG, Abdel-Rasoul M, Boyle B, Dotson JL, Michel HK, Maltz RM. Clinical impacts of immunomodulator withdrawal from anti-tumor necrosis factor combination therapy in pediatric inflammatory bowel disease. J Pediatr Gastroenterol Nutr. 2024 Oct; 79(4):885-894.
    View in: PubMed
    Score: 0.195
  4. Vergidis P, Avery RK, Wheat LJ, Dotson JL, Assi MA, Antoun SA, Hamoud KA, Burdette SD, Freifeld AG, McKinsey DS, Money ME, Myint T, Andes DR, Hoey CA, Kaul DA, Dickter JK, Liebers DE, Miller RA, Muth WE, Prakash V, Steiner FT, Walker RC, Hage CA. Histoplasmosis complicating tumor necrosis factor-a blocker therapy: a retrospective analysis of 98 cases. Clin Infect Dis. 2015 Aug 01; 61(3):409-17.
    View in: PubMed
    Score: 0.103
  5. Geem D, Hercules D, Pelia RS, Venkateswaran S, Griffiths A, Noe JD, Dotson JL, Snapper S, Rabizadeh S, Rosh JR, Baldassano RN, Markowitz JF, Walters TD, Ananthakrishnan A, Sharma G, Denson LA, Hyams JS, Kugathasan S. Progression of Pediatric Crohn's Disease Is Associated With Anti-Tumor Necrosis Factor Timing and Body Mass Index Z-Score Normalization. Clin Gastroenterol Hepatol. 2024 02; 22(2):368-376.e4.
    View in: PubMed
    Score: 0.046
  6. Yossef L, Wright M, Benedict J, Morris GA, McNicol M, Boyle B, Dotson JL, Michel HK, Maltz RM. Patient and Caregivers' Perspectives on Biosimilar Use in Pediatric Inflammatory Bowel Disease. J Pediatr Gastroenterol Nutr. 2022 07 01; 75(1):59-63.
    View in: PubMed
    Score: 0.042
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.